Design and synthesis of 8-octyl-benzolactam-V9, a selective activator for protein kinase Cε and η

Journal of Medicinal Chemistry

Volumn 49, Issue 9, 2006, Pages 2681-2688

  Nakagawa, Yu ^a   Irie, Kazuhiro ^a   Yanagita, Ryo C ^a   Ohigashi, Hajime ^a   Tsuda, Ken Ichiro ^b   Kashiwagi, Kaori ^c   Saito, Naoaki ^c  

^a KYOTO UNIVERSITY   (Japan)

^b NEC CORPORATION   (Japan)

^c KOBE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 OCTYL BENZOLACTAM V9; INDOLACTAM V; INDOLINELACTAM V DERIVATIVE; ISOENZYME; LACTAM DERIVATIVE; PHORBOL ESTER; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C ETA; PROTEIN KINASE C GAMMA; PROTEIN KINASE C THETA; PYRROLIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DRUG BINDING; DRUG CONFORMATION; DRUG DESIGN; DRUG SELECTIVITY; DRUG SYNTHESIS; HELA CELL; HUMAN; HUMAN CELL; TUMOR PROMOTION;

DRUG DESIGN; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HELA CELLS; HUMANS; ISOENZYMES; LACTAMS; MOLECULAR STRUCTURE; PROTEIN KINASE C; PROTEIN TRANSPORT;

EID: 33646457937     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm050857c     Document Type: Article

References (33)

1. Nishizuka, Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 1984, 308, 693-698.
2. Nishizuka, Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 1995, 9, 484-496.
3. Fujiki, H.; Sugimura, T. New classes of tumor promoters: teleocidin, aplysiatoxin, and palytoxin. Adv. Cancer Res. 1987, 49, 223-264.
4. Castagna, M.; Takai, Y.; Kaibuchi, K.; Sano, K.; Kikkawa, U.; Nishizuka, Y. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J. Biol. Chem. 1982, 257, 7847-7851.
5. Endo, Y.; Shudo, K.; Okamoto, T. Molecular requirements for epigenetic modulators. Synthesis of active fragments of teleocidins and lyngbyatoxin. Chem. Pharm. Bull. 1982, 30, 3457-3460.
6. Irie, K.; Hirota, M.; Hagiwara, N.; Koshimizu, K.; Hayashi, H.; Murao, S.; Tokuda, H.; Ito, Y. The Epstein-Barr virus early antigen inducing indole alkaloids, (-)-indolactam V and its related compounds produced by Actinomycetes. Agric. Biol. Chem. 1984, 48, 1269-1274.
7. Kazanietz, M. G.; Areces, L. B.; Bahador, A.; Mischak, H.; Goodnight, J.; Mushinski, J. F.; Blumberg, P. M. Characterization of ligand and substrate specificity for the calcium-dependent and calcium-independent protein kinase C isozymes. Mol. Pharmacol. 1993, 44, 298-307.
8. Hurley, J. H.; Newton, A. C.; Parker, P. J.; Blumberg, P. M.; Nishizuka, Y. Taxonomy and functions of C1 protein kinase C homology domains. Protein Sci. 1997, 6, 477-480.
9. Reddig, P. J.; Dreckschimdt, N. E.; Ahrens, H.; Simsiman, R.; Tseng, C.-P.; Zou, J.; Oberley, T. D.; Verma, A. K. Transgenic mice overexpressing protein kinase Cδ in the epidermis are resistant to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 1999, 59, 5710-5718.
10. Chida, K.; Hara, T.; Hirai, T.; Konishi, C.; Nakamura, K.; Nakao, K.; Aiba, A.; Katsuki, M.; Kuroki, T. Disruption of protein kinase Cη results in impairment of wound healing and enhancement of tumor formation of mouse skin carcinogenesis. Cancer Res. 2003, 63, 2404-2408.
11. Reddig, P. J.; Dreckschmidt, N. E.; Zou, J.; Bourguignon, S. E.; Oberley, T. D.; Verma, A. K. Transgenic mice overexpressing protein kinase Cε in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion. Cancer Res. 2000, 60, 595-602.
12. Szallasi, Z.; Bögi, K.; Gohari, S.; Biro, T.; Acs, P.; Blumberg, P. M. Non-equivalent roles for the first and second zinc fingers of protein kinase Co. J. Biol. Chem. 1996, 271, 18299-18301.
13. Hunn, M.; Quest, A. F. G. Cysteine-rich regions of protein kinase Cδ are functionally non-equivalent. FEBS Lett. 1997, 271, 18299-18301.
14. Shindo, M.; Irie, K.; Nakahara, A.; Ohigashi, H.; Konishi, H.; Kikkawa, U.; Fukuda, H.; Wender, P. A. Toward the identification of selective modulators of protein kinase C (PKC) isozymes: establishment of a binding assay for PKC isozymes using synthetic C1 peptide receptors and identification of the critical residues involved in the phorbol ester binding. Bioorg. Med. Chem. 2001, 9, 2073-2081.
15. Irie, K.; Oie, K.; Nakahara, A.; Yanai, Y.; Ohigashi, H.; Wender, P. A.; Satomi, Y.; Nishino, H. Molecular basis for protein kinase C isozyme-selective binding: the synthesis, folding, and phorbol ester binding of the cysteine-rich domains of all protein kinase C isozymes. J. Am. Chem. Soc. 1998, 120, 9159-9167.
16. Irie, K.; Nakahara, A.; Nakagawa, Y.; Ohigashi, H.; Shindo, M.; Fukuda, H.; Konishi, H.; Kikkawa, U.; Kashiwagi, K.; Saito, N. Establishment of a binding assay for protein kinase C isozymes using synthetic C1 peptides and development of new medicinal leads with protein kinase C isozymes and C1 domain selectivity. Pharmacol. Ther. 2002, 93, 271-281.
17. Nakagawa, Y.; Irie, K.; Komiya, Y.; Ohigashi, H.; Tsuda, K. Synthesis, conformation and PKC isozyme surrogate binding of indolinelactam-Vs. new conformationally restricted analogues of (-)-indolactam-V. Tetrahedron 2004, 60, 7077-7084.
18. Irie, K.; Nakagawa, Y.; Ohigashi, H. Toward the development of new medicinal leads with selectivity for protein kinase C isozymes. Chem. Rec. 2005, 5, 185-195.
19. Irie, K.; Isaka, T.; Iwata, Y.; Yanai, Y.; Nakamura, Y.; Koizumi, F.; Ohigashi, H.; Wender, P. A.; Satomi, Y.; Nishino, H. Synthesis and biological activities of new conformationally restricted analogues of (-)-indolactam-V: elucidation of the biologically active conformation of the tumor-promoting teleocidins. J. Am. Chem. Soc. 1996, 118, 10733-10743.
20. Endo, Y.; Ohno, M.; Hirano, M.; Itai, A.; Shudo, K. Synthesis, conformation, and biological activity of teleocidin mimics, benzolactams. A clarification of the conformational flexibility problem in structure-activity studies of teleocidins. J. Am. Chem. Soc. 1996, 118, 1841-1855.
21. Thorand, S.; Krause, N. Improved procedures for the palladium-catalyzed coupling of terminal alkynes with aryl bromides (Sonogashira coupling). J. Org. Chem. 1998, 63, 8551-8553.
22. Kogan, T. P.; Somers, T. C.; Venuti, M. C. A regio- and stereo-controlled total synthesis of (-)-indolactam-V. Tetrahedron 1990, 46, 6623-6632.
23. Chakraborty, T. K.; Hussain, K. A.; Reddy, G. V. α-Phenylglycinol as chiral auxiliary in diastereoselective Strecker synthesis of α-amino acids. Tetrahedron 1995, 51, 9179-9190.
24. Kawai, T.; Ichinose, T.; Takeda, M.; Tomioka, N.; Endo, Y.; Yamaguchi, K.; Shudo, K.; Itai, A. Prediction of ring conformations of indolactams. Crystal and solution structures. J. Org. Chem. 1992, 57, 6150-6155.
25. 3H]phorbol 12,13-dibutyrate binding. Cancer Res. 1985, 45, 19-24.
26. Kraft, A. S.; Anderson, W. B.; Cooper, H. L.; Sando, J. J. Decrease in cytosolic calcium/phospholipid-dependent protein kinase activity following phorbol ester treatment of ELA4 thymoma cells. J. Biol. Chem. 1982, 257, 13193-13196.
27. Wada, R.; Suto, Y.; Kanai, M.; Shibasaki, M. Dramatic switching of protein kinase C agonist/antagonist activity by modifying the 12-ester side chain of phorbol esters. J. Am. Chem. Soc. 2002, 124, 10658-10659.
28. Sakai, N.; Sasaki, K.; Ikegaki, N.; Shirai, Y.; Ono, Y.; Saito, N. Direct Visualization of the translocation of the γ-subspecies of protein kinase C in living cells using fusion proteins with green fluorescent protein. J. Cell Biol. 1997, 139, 1465-1476.
29. Oancea, E.; Meyer, T. Protein kinase C as a machine for decoding calcium and diacylglycerol signals. Cell 1998, 95, 307-318.
30. Wang, Q. J.; Bhattacharyya, D.; Garfield, S.; Nacro, K.; Marquez, V. E.; Blumberg, P. M. Differential localization of protein kinase C δ by phorbol esters and related compounds using a fusion protein with green fluorescent protein. J. Biol. Chem. 1999, 274, 37233-37239.
31. Ohmori, S.; Sakai, N.; Shirai, Y.; Yamamoto, H.; Miyamoto, E.; Shimizu, H.; Saito, N. Importance of protein kinase C targeting for the phosphorylation of its substrate, myristoylated alanine-rich C-kinase substrate. J. Biol. Chem. 2000, 275, 26449-26457.
32. Nakagawa, Y.; Irie, K.; Yanagita, R. C.; Ohigashi, H.; Tsuda, K. Indolactam-V is involved in the CH/π interaction with Pro-11 of the PKCδ C1B domain: application for the structural optimization of the PKCδ ligand. J. Am. Chem. Soc. 2005, 127, 5746-5747.
33. Garcia-Bermejo, M. L.; Leskow, F. C.; Fujii, T.; Wang, Q.; Blumberg, P. M.; Ohba, M.; Kuroki, T.; Han, K.-C.; Lee, J.; Marquez, V. E.; Kazanietz, M. G. Diacylglycerol (DAG)-lactones, a new class of protein kinase C (PKC) agonists, induce apoptosis in LNCaP prostate cancer cells by selective activation of PKCα. J. Biol. Chem. 2002, 277, 645-655.